Molecular mechanisms and consequences of TDP-43 phosphorylation in neurodegeneration

Increased phosphorylation of TDP-43 is a pathological hallmark of several neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, the regulation and roles of TDP-43 phosphorylation remain incompletely understood. A variety of techniques...

Full description

Saved in:
Bibliographic Details
Published inMolecular neurodegeneration Vol. 20; no. 1; pp. 53 - 35
Main Authors Kellett, Elise A., Bademosi, Adekunle T., Walker, Adam K.
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 08.05.2025
BMC
Subjects
Amino acids
Amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis - metabolism
Animals
Dementia
Development and progression
DNA-Binding Proteins - metabolism
Frontotemporal dementia
Humans
Nervous system diseases
Neurodegeneration
Neurodegenerative Diseases - metabolism
Neurophysiology
Phosphorylation
Phosphorylation - physiology
Post-translational modification
Post-translational modifications
TDP-43
Phosphorylation
Post-translational modifications
Kinase
Neurodegeneration
TDP-43
Amyotrophic lateral sclerosis
Frontotemporal dementia
Phosphatase
Online AccessGet full text

Cover

Abstract Increased phosphorylation of TDP-43 is a pathological hallmark of several neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, the regulation and roles of TDP-43 phosphorylation remain incompletely understood. A variety of techniques have been utilized to understand TDP-43 phosphorylation, including kinase/phosphatase manipulation, phosphomimic variants, and genetic, physical, or chemical inducement in a variety of cell cultures and animal models, and via analyses of post-mortem human tissues. These studies have produced conflicting results: suggesting incongruously that TDP-43 phosphorylation may either drive disease progression or serve a neuroprotective role. In this review, we explore the roles of regulators of TDP-43 phosphorylation including the putative TDP-43 kinases c-Abl, CDC7, CK1, CK2, IKKβ, p38α/MAPK14, MEK1, TTBK1, and TTBK2, and TDP-43 phosphatases PP1, PP2A, and PP2B, in disease. Building on recent studies, we also examine the consequences of TDP-43 phosphorylation on TDP-43 pathology, especially related to TDP-43 mislocalisation, liquid–liquid phase separation, aggregation, and neurotoxicity. By comparing conflicting findings from various techniques and models, this review highlights both the discrepancies and unresolved aspects in the understanding of TDP-43 phosphorylation. We propose that the role of TDP-43 phosphorylation is site and context dependent, and includes regulation of liquid–liquid phase separation, subcellular mislocalisation, and degradation. We further suggest that greater consideration of the normal functions of the regulators of TDP-43 phosphorylation that may be perturbed in disease is warranted. This synthesis aims to build towards a comprehensive understanding of the complex role of TDP-43 phosphorylation in the pathogenesis of neurodegeneration. Graphical Abstract TDP-43 is subject to phosphorylation by kinases and dephosphorylation by phosphatases, which variably impacts protein localisation, aggregation, and neurotoxicity in neurodegenerative diseases.
AbstractList Abstract Increased phosphorylation of TDP-43 is a pathological hallmark of several neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, the regulation and roles of TDP-43 phosphorylation remain incompletely understood. A variety of techniques have been utilized to understand TDP-43 phosphorylation, including kinase/phosphatase manipulation, phosphomimic variants, and genetic, physical, or chemical inducement in a variety of cell cultures and animal models, and via analyses of post-mortem human tissues. These studies have produced conflicting results: suggesting incongruously that TDP-43 phosphorylation may either drive disease progression or serve a neuroprotective role. In this review, we explore the roles of regulators of TDP-43 phosphorylation including the putative TDP-43 kinases c-Abl, CDC7, CK1, CK2, IKKβ, p38α/MAPK14, MEK1, TTBK1, and TTBK2, and TDP-43 phosphatases PP1, PP2A, and PP2B, in disease. Building on recent studies, we also examine the consequences of TDP-43 phosphorylation on TDP-43 pathology, especially related to TDP-43 mislocalisation, liquid–liquid phase separation, aggregation, and neurotoxicity. By comparing conflicting findings from various techniques and models, this review highlights both the discrepancies and unresolved aspects in the understanding of TDP-43 phosphorylation. We propose that the role of TDP-43 phosphorylation is site and context dependent, and includes regulation of liquid–liquid phase separation, subcellular mislocalisation, and degradation. We further suggest that greater consideration of the normal functions of the regulators of TDP-43 phosphorylation that may be perturbed in disease is warranted. This synthesis aims to build towards a comprehensive understanding of the complex role of TDP-43 phosphorylation in the pathogenesis of neurodegeneration. Graphical Abstract TDP-43 is subject to phosphorylation by kinases and dephosphorylation by phosphatases, which variably impacts protein localisation, aggregation, and neurotoxicity in neurodegenerative diseases.
Increased phosphorylation of TDP-43 is a pathological hallmark of several neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, the regulation and roles of TDP-43 phosphorylation remain incompletely understood. A variety of techniques have been utilized to understand TDP-43 phosphorylation, including kinase/phosphatase manipulation, phosphomimic variants, and genetic, physical, or chemical inducement in a variety of cell cultures and animal models, and via analyses of post-mortem human tissues. These studies have produced conflicting results: suggesting incongruously that TDP-43 phosphorylation may either drive disease progression or serve a neuroprotective role. In this review, we explore the roles of regulators of TDP-43 phosphorylation including the putative TDP-43 kinases c-Abl, CDC7, CK1, CK2, IKKβ, p38α/MAPK14, MEK1, TTBK1, and TTBK2, and TDP-43 phosphatases PP1, PP2A, and PP2B, in disease. Building on recent studies, we also examine the consequences of TDP-43 phosphorylation on TDP-43 pathology, especially related to TDP-43 mislocalisation, liquid-liquid phase separation, aggregation, and neurotoxicity. By comparing conflicting findings from various techniques and models, this review highlights both the discrepancies and unresolved aspects in the understanding of TDP-43 phosphorylation. We propose that the role of TDP-43 phosphorylation is site and context dependent, and includes regulation of liquid-liquid phase separation, subcellular mislocalisation, and degradation. We further suggest that greater consideration of the normal functions of the regulators of TDP-43 phosphorylation that may be perturbed in disease is warranted. This synthesis aims to build towards a comprehensive understanding of the complex role of TDP-43 phosphorylation in the pathogenesis of neurodegeneration.Increased phosphorylation of TDP-43 is a pathological hallmark of several neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, the regulation and roles of TDP-43 phosphorylation remain incompletely understood. A variety of techniques have been utilized to understand TDP-43 phosphorylation, including kinase/phosphatase manipulation, phosphomimic variants, and genetic, physical, or chemical inducement in a variety of cell cultures and animal models, and via analyses of post-mortem human tissues. These studies have produced conflicting results: suggesting incongruously that TDP-43 phosphorylation may either drive disease progression or serve a neuroprotective role. In this review, we explore the roles of regulators of TDP-43 phosphorylation including the putative TDP-43 kinases c-Abl, CDC7, CK1, CK2, IKKβ, p38α/MAPK14, MEK1, TTBK1, and TTBK2, and TDP-43 phosphatases PP1, PP2A, and PP2B, in disease. Building on recent studies, we also examine the consequences of TDP-43 phosphorylation on TDP-43 pathology, especially related to TDP-43 mislocalisation, liquid-liquid phase separation, aggregation, and neurotoxicity. By comparing conflicting findings from various techniques and models, this review highlights both the discrepancies and unresolved aspects in the understanding of TDP-43 phosphorylation. We propose that the role of TDP-43 phosphorylation is site and context dependent, and includes regulation of liquid-liquid phase separation, subcellular mislocalisation, and degradation. We further suggest that greater consideration of the normal functions of the regulators of TDP-43 phosphorylation that may be perturbed in disease is warranted. This synthesis aims to build towards a comprehensive understanding of the complex role of TDP-43 phosphorylation in the pathogenesis of neurodegeneration.
Increased phosphorylation of TDP-43 is a pathological hallmark of several neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, the regulation and roles of TDP-43 phosphorylation remain incompletely understood. A variety of techniques have been utilized to understand TDP-43 phosphorylation, including kinase/phosphatase manipulation, phosphomimic variants, and genetic, physical, or chemical inducement in a variety of cell cultures and animal models, and via analyses of post-mortem human tissues. These studies have produced conflicting results: suggesting incongruously that TDP-43 phosphorylation may either drive disease progression or serve a neuroprotective role. In this review, we explore the roles of regulators of TDP-43 phosphorylation including the putative TDP-43 kinases c-Abl, CDC7, CK1, CK2, IKKβ, p38α/MAPK14, MEK1, TTBK1, and TTBK2, and TDP-43 phosphatases PP1, PP2A, and PP2B, in disease. Building on recent studies, we also examine the consequences of TDP-43 phosphorylation on TDP-43 pathology, especially related to TDP-43 mislocalisation, liquid–liquid phase separation, aggregation, and neurotoxicity. By comparing conflicting findings from various techniques and models, this review highlights both the discrepancies and unresolved aspects in the understanding of TDP-43 phosphorylation. We propose that the role of TDP-43 phosphorylation is site and context dependent, and includes regulation of liquid–liquid phase separation, subcellular mislocalisation, and degradation. We further suggest that greater consideration of the normal functions of the regulators of TDP-43 phosphorylation that may be perturbed in disease is warranted. This synthesis aims to build towards a comprehensive understanding of the complex role of TDP-43 phosphorylation in the pathogenesis of neurodegeneration. Graphical Abstract TDP-43 is subject to phosphorylation by kinases and dephosphorylation by phosphatases, which variably impacts protein localisation, aggregation, and neurotoxicity in neurodegenerative diseases.
Increased phosphorylation of TDP-43 is a pathological hallmark of several neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, the regulation and roles of TDP-43 phosphorylation remain incompletely understood. A variety of techniques have been utilized to understand TDP-43 phosphorylation, including kinase/phosphatase manipulation, phosphomimic variants, and genetic, physical, or chemical inducement in a variety of cell cultures and animal models, and via analyses of post-mortem human tissues. These studies have produced conflicting results: suggesting incongruously that TDP-43 phosphorylation may either drive disease progression or serve a neuroprotective role. In this review, we explore the roles of regulators of TDP-43 phosphorylation including the putative TDP-43 kinases c-Abl, CDC7, CK1, CK2, IKK[beta], p38[alpha]/MAPK14, MEK1, TTBK1, and TTBK2, and TDP-43 phosphatases PP1, PP2A, and PP2B, in disease. Building on recent studies, we also examine the consequences of TDP-43 phosphorylation on TDP-43 pathology, especially related to TDP-43 mislocalisation, liquid-liquid phase separation, aggregation, and neurotoxicity. By comparing conflicting findings from various techniques and models, this review highlights both the discrepancies and unresolved aspects in the understanding of TDP-43 phosphorylation. We propose that the role of TDP-43 phosphorylation is site and context dependent, and includes regulation of liquid-liquid phase separation, subcellular mislocalisation, and degradation. We further suggest that greater consideration of the normal functions of the regulators of TDP-43 phosphorylation that may be perturbed in disease is warranted. This synthesis aims to build towards a comprehensive understanding of the complex role of TDP-43 phosphorylation in the pathogenesis of neurodegeneration. Graphical TDP-43 is subject to phosphorylation by kinases and dephosphorylation by phosphatases, which variably impacts protein localisation, aggregation, and neurotoxicity in neurodegenerative diseases. Keywords: TDP-43, Phosphorylation, Amyotrophic lateral sclerosis, Frontotemporal dementia, Post-translational modifications, Neurodegeneration, Kinase, Phosphatase
Increased phosphorylation of TDP-43 is a pathological hallmark of several neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, the regulation and roles of TDP-43 phosphorylation remain incompletely understood. A variety of techniques have been utilized to understand TDP-43 phosphorylation, including kinase/phosphatase manipulation, phosphomimic variants, and genetic, physical, or chemical inducement in a variety of cell cultures and animal models, and via analyses of post-mortem human tissues. These studies have produced conflicting results: suggesting incongruously that TDP-43 phosphorylation may either drive disease progression or serve a neuroprotective role. In this review, we explore the roles of regulators of TDP-43 phosphorylation including the putative TDP-43 kinases c-Abl, CDC7, CK1, CK2, IKK[beta], p38[alpha]/MAPK14, MEK1, TTBK1, and TTBK2, and TDP-43 phosphatases PP1, PP2A, and PP2B, in disease. Building on recent studies, we also examine the consequences of TDP-43 phosphorylation on TDP-43 pathology, especially related to TDP-43 mislocalisation, liquid-liquid phase separation, aggregation, and neurotoxicity. By comparing conflicting findings from various techniques and models, this review highlights both the discrepancies and unresolved aspects in the understanding of TDP-43 phosphorylation. We propose that the role of TDP-43 phosphorylation is site and context dependent, and includes regulation of liquid-liquid phase separation, subcellular mislocalisation, and degradation. We further suggest that greater consideration of the normal functions of the regulators of TDP-43 phosphorylation that may be perturbed in disease is warranted. This synthesis aims to build towards a comprehensive understanding of the complex role of TDP-43 phosphorylation in the pathogenesis of neurodegeneration.
Increased phosphorylation of TDP-43 is a pathological hallmark of several neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, the regulation and roles of TDP-43 phosphorylation remain incompletely understood. A variety of techniques have been utilized to understand TDP-43 phosphorylation, including kinase/phosphatase manipulation, phosphomimic variants, and genetic, physical, or chemical inducement in a variety of cell cultures and animal models, and via analyses of post-mortem human tissues. These studies have produced conflicting results: suggesting incongruously that TDP-43 phosphorylation may either drive disease progression or serve a neuroprotective role. In this review, we explore the roles of regulators of TDP-43 phosphorylation including the putative TDP-43 kinases c-Abl, CDC7, CK1, CK2, IKKβ, p38α/MAPK14, MEK1, TTBK1, and TTBK2, and TDP-43 phosphatases PP1, PP2A, and PP2B, in disease. Building on recent studies, we also examine the consequences of TDP-43 phosphorylation on TDP-43 pathology, especially related to TDP-43 mislocalisation, liquid-liquid phase separation, aggregation, and neurotoxicity. By comparing conflicting findings from various techniques and models, this review highlights both the discrepancies and unresolved aspects in the understanding of TDP-43 phosphorylation. We propose that the role of TDP-43 phosphorylation is site and context dependent, and includes regulation of liquid-liquid phase separation, subcellular mislocalisation, and degradation. We further suggest that greater consideration of the normal functions of the regulators of TDP-43 phosphorylation that may be perturbed in disease is warranted. This synthesis aims to build towards a comprehensive understanding of the complex role of TDP-43 phosphorylation in the pathogenesis of neurodegeneration.
ArticleNumber 53
Audience Academic
Author Walker, Adam K.
Bademosi, Adekunle T.
Kellett, Elise A.
Author_xml – sequence: 1
  givenname: Elise A.
  surname: Kellett
  fullname: Kellett, Elise A.
– sequence: 2
  givenname: Adekunle T.
  surname: Bademosi
  fullname: Bademosi, Adekunle T.
– sequence: 3
  givenname: Adam K.
  orcidid: 0000-0001-7954-5801
  surname: Walker
  fullname: Walker, Adam K.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40340943$$D View this record in MEDLINE/PubMed
BookMark eNptkk9vFSEUxYmpse3TL-DCTOLGzVT-DsyyabVtUqOL55owcHmlmYEnzCz67eW9qY0mhhDIyY8T7r3nHJ3EFAGh9wRfEKK6z4UwTHmLqWgxVqxv1St0RqTALWG0O_nrforOS3nEmEuMxRt0yjHjuOfsDG2_pRHsMprcTGAfTAxlKo2JrrEpFvi1QLRQmuSb7fWPlrNm_5BK3flpNHNIsQmxibDk5GAHEfJRfIteezMWePd8btDPr1-2V7ft_febu6vL-9ZyxubWDr6TgnJPpDVCuN66zsl-UIpVsdbWd4QYR2UP0jDlgTBg2ErWGWJsP7ANult9XTKPep_DZPKTTiboo5DyTps8BzuCdsKYbqCKeKB8MGywhA5ScAwwKF9bsUGfVq99TrXqMuspFAvjaCKkpWhGMSUCKyor-nFFd6Y6h-jTnI094PqyjgFz0fGD4cV_qLocTKE2F3yo-j8PPjz_YBkmcC_1_BlWBegK2JxKyeBfEIL1IRF6TYSuidDHRGjFfgNu66aU
Cites_doi 10.1016/j.tibs.2010.03.002
10.1073/pnas.88.21.9548
10.1016/S0896-6273(01)00554-2
10.1093/brain/awr053
10.1523/JNEUROSCI.6513-10.2011
10.1093/nar/gkq1104
10.1074/jbc.M116.753913
10.1038/s41598-018-25008-4
10.1038/s41594-020-0399-3
10.3390/cells11243972
10.1074/jbc.M009134200
10.1074/jbc.270.21.12717
10.1523/JNEUROSCI.23-07-02557.2003
10.1016/j.cell.2015.07.047
10.1016/j.bbamcr.2006.10.005
10.1016/j.bbamcr.2014.04.020
10.1111/j.1460-9568.2005.04391.x
10.1007/s12035-019-1547-9
10.1111/j.1365-2990.2006.00795.x
10.3390/brainsci10100675
10.1371/journal.pone.0140248
10.1177/1758834014530023
10.1111/j.1471-4159.2009.06383.x
10.1016/j.expneurol.2015.07.019
10.1038/nn.2779
10.1186/s40478-021-01281-9
10.1074/jbc.M115.695379
10.1007/s00401-010-0759-x
10.1186/1476-4598-13-231
10.1111/j.1471-4159.2010.07098.x
10.1038/sj.cdd.4401604
10.1016/j.nbd.2021.105548
10.1038/s41467-017-00480-0
10.1074/jbc.M002850200
10.3389/fchem.2022.835733
10.1016/j.molcel.2018.07.002
10.1074/jbc.272.6.3296
10.3389/fcell.2021.698661
10.3389/fncel.2016.00204
10.1007/s00018-023-04739-2
10.1074/jbc.C000099200
10.1083/jcb.201412075
10.1016/S0065-2660(09)66001-6
10.1074/jbc.270.25.14875
10.1093/emboj/18.19.5334
10.1007/s00401-008-0477-9
10.1038/ncb748
10.1016/j.mrfmmm.2003.08.008
10.1016/j.febslet.2008.07.027
10.1096/fj.02-0473rev
10.1016/j.brainres.2007.09.048
10.1093/brain/awab217
10.1038/s41557-020-0465-9
10.1126/science.abb4309
10.1038/srep03460
10.1074/jbc.M703269200
10.3390/ijms20215501
10.1016/S0092-8674(01)00610-9
10.1016/j.neuron.2004.07.022
10.1523/JNEUROSCI.1444-16.2016
10.4103/1673-5374.276320
10.1097/00003246-200004001-00008
10.1038/s41467-020-16580-3
10.1016/j.molcel.2015.08.018
10.1212/01.wnl.0000304041.09418.b1
10.1016/S0197-4580(00)00110-X
10.1371/journal.pone.0046185
10.1126/scitranslmed.aaf3962
10.1038/s41598-018-25767-0
10.1038/srep43295
10.1093/nar/gkh253
10.1101/cshperspect.a024117
10.1016/j.nbd.2020.105078
10.1134/S0006297918060056
10.1016/S0002-9440(10)65219-4
10.1016/j.nbd.2020.105051
10.1038/ncomms6845
10.1093/hmg/ddp303
10.1016/0092-8674(94)90277-1
10.1128/MCB.19.7.4888
10.1128/MCB.20.13.4888-4899.2000
10.1002/glia.23606
10.1007/s00401-016-1600-y
10.1016/j.celrep.2024.115205
10.1016/j.neurobiolaging.2018.08.025
10.1002/1873-3468.12976
10.1371/journal.pone.0141836
10.1172/JCI85456
10.1242/jcs.01655
10.1093/jnen/63.4.287
10.1038/s41598-020-61265-y
10.1007/s00401-018-1942-8
10.1093/emboj/cdf290
10.1074/jbc.275.1.390
10.3390/cells10030565
10.1111/j.1471-4159.1993.tb03603.x
10.1073/pnas.0308512100
10.1093/emboj/16.18.5537
10.1523/JNEUROSCI.1487-05.2005
10.3390/ijms22168975
10.1016/0014-5793(94)80247-5
10.1093/hmg/ddt674
10.1002/cbic.201200093
10.1371/journal.pone.0023414
10.1126/scitranslmed.adf9735
10.1101/2021.10.06.21264635
10.1016/0306-4522(94)90400-6
10.1128/jb.178.16.4759-4764.1996
10.1016/S0002-9440(10)63879-5
10.4161/org.4.2.5851
10.3389/fphar.2021.648636
10.3233/JAD-180874
10.1016/0006-8993(90)90282-G
10.1093/hmg/ddt498
10.1007/s00401-020-02242-7
10.1152/physrev.2000.80.4.1483
10.1371/journal.pgen.1004803
10.1016/S0014-5793(01)02256-6
10.1073/pnas.89.20.9454
10.3389/fmolb.2022.906437
10.1126/science.1154584
10.15252/embj.201797452
10.3390/biomedicines9080969
10.1016/j.neuron.2013.12.018
10.1111/jnc.15118
10.1016/S0898-6568(99)00071-6
10.1093/brain/awt029
10.1016/j.ejmech.2020.112968
10.1093/hmg/ddt319
10.1128/MCB.01279-10
10.1016/j.tcb.2018.02.004
10.1016/j.febslet.2007.08.067
10.1016/S0014-5793(02)03274-X
10.1093/hmg/ddq137
10.1016/j.neuron.2019.01.048
10.3233/JAD-2010-1271
10.1016/j.bbrc.2006.10.093
10.1074/jbc.M110.190884
10.1046/j.1471-4159.1995.65062804.x
10.15252/embj.201798049
10.1016/S0896-6273(00)80250-0
10.1016/bs.apcsb.2019.08.002
10.1016/j.bbrc.2009.03.038
10.7554/eLife.39578
10.1083/jcb.202302048
10.1007/s00401-008-0408-9
10.1038/s41582-019-0157-5
10.1074/jbc.M200486200
10.1016/j.celrep.2019.10.061
10.1016/S0140-6736(16)00737-6
10.1038/emboj.2011.471
10.1006/exnr.2001.7630
10.1101/2023.06.21.546009
10.1006/exnr.2000.7534
10.1093/brain/aww028
10.3390/cells10040839
10.1371/journal.pone.0142296
10.1017/S0033583511000060
10.3233/JAD-2010-100987
10.1152/physrev.2001.81.2.807
10.1007/s11064-019-02832-2
10.1371/journal.pone.0023075
10.1371/journal.pone.0090452
10.1523/JNEUROSCI.21-08-02661.2001
10.1038/srep23281
10.1074/jbc.AC117.001037
10.1007/s00401-018-1870-7
10.1016/j.pneurobio.2022.102229
10.1016/j.ejcb.2021.151179
10.1073/pnas.0611236104
10.1371/journal.pone.0232019
10.1042/bj20021469
10.1074/jbc.R115.695056
10.1128/MCB.20.1.242-248.2000
10.3390/ijms22083875
10.1016/S0021-9258(17)41790-X
10.1016/j.nbd.2024.106516
10.1007/s00401-013-1211-9
10.1074/mcp.M700564-MCP200
10.1016/j.celrep.2022.111007
10.1097/NEN.0b013e31818e8951
10.1074/jbc.M109.010264
10.1016/j.canlet.2013.02.036
10.1101/2024.08.19.608477
10.1097/00005072-199608000-00008
10.1007/s00401-007-0261-2
10.1083/jcb.202103033
10.1021/acschembio.3c00068
10.1016/S0166-2236(00)01930-5
10.1016/j.tig.2022.06.004
10.1038/s41586-024-07487-w
10.1126/science.1134108
10.1038/s41593-018-0300-4
10.1016/j.cbpa.2015.07.001
10.1016/S0092-8674(02)00685-2
10.1038/sj.cr.7290257
10.1016/j.neuron.2013.07.033
10.1093/nar/gkt1407
10.1016/j.cell.2015.09.015
10.1074/jbc.M005541200
10.3389/fonc.2021.733700
10.1046/j.1471-4159.1995.64031420.x
10.1074/jbc.275.8.5535
10.1098/rsob.130061
10.1016/j.nbd.2011.12.002
10.1016/j.febslet.2014.12.029
10.1016/S0006-8993(00)02200-9
10.1016/0014-5793(93)80850-T
10.3389/fnmol.2023.1243277
10.1101/2025.02.28.639952
10.1021/jm500065f
10.1523/JNEUROSCI.0172-14.2014
10.1111/j.1471-4159.2004.02588.x
10.1002/ana.23870
10.1016/j.molcel.2015.01.013
10.1038/s41586-022-04436-3
10.15252/embj.201696394
10.1074/jbc.M312760200
10.3390/biom11040548
10.1186/s13024-020-00420-5
10.1016/j.ymthe.2016.10.013
10.1038/s41586-022-04424-7
10.15252/embj.2021108443
10.1074/jbc.M800747200
10.1523/JNEUROSCI.1833-10.2011
10.1042/BJ20081135
10.1073/pnas.0506806103
10.1371/journal.ppat.1008495
10.1007/s00401-015-1460-x
10.1038/s41593-018-0293-z
10.1111/nan.12836
10.3389/fnmol.2017.00170
10.1016/j.molcel.2009.02.015
10.1038/s41593-018-0294-y
10.1074/mcp.M800390-MCP200
10.1016/j.str.2016.07.007
10.3390/cancers14051345
10.1038/emboj.2010.310
10.1186/s13024-018-0237-9
10.1016/j.brainres.2016.04.069
10.1016/j.neuron.2019.02.038
10.1007/s10571-020-00875-6
10.1111/j.1471-4159.2006.04059.x
10.1002/ana.20379
10.1006/nbdi.1997.0145
10.1007/s00401-008-0480-1
10.1046/j.1471-4159.1994.62020803.x
10.1111/j.1471-4159.2012.07871.x
10.1111/bpa.12775
10.21203/rs.3.rs-5334588/v1
10.1016/j.bbrc.2012.07.071
10.1016/j.biocel.2010.12.004
10.2174/1874375701004010011
10.1093/cercor/bhr004
10.1016/j.advenzreg.2008.04.002
10.1074/jbc.275.11.7470
10.1016/j.molmed.2009.01.003
10.1038/nm.4130
10.1101/gad.230302
10.1021/acs.jmedchem.1c01942
10.3389/fneur.2018.00218
10.1007/s12035-018-1249-8
10.1186/s13024-016-0102-7
10.1007/s00702-005-0313-5
10.1074/jbc.M406240200
10.1038/nri2423
10.1038/cddis.2014.175
10.3390/ijms21176259
10.1126/science.1172046
10.1016/j.str.2020.05.010
10.15252/emmm.201708202
10.1091/mbc.E17-12-0735
10.1016/j.neuroscience.2015.02.046
10.1172/JCI44867
10.1007/s00432-018-2737-y
10.1016/j.jbc.2022.102191
10.1016/j.redox.2018.11.017
10.1084/jem.20111313
10.1078/S0171-9335(04)70027-8
10.1186/s12974-015-0470-x
10.1038/ng.132
10.1074/jbc.270.9.4854
10.1074/jbc.M314116200
10.1046/j.1471-4159.1995.65020732.x
10.1046/j.1471-4159.2003.01670.x
10.1093/emboj/18.23.6845
10.1523/JNEUROSCI.0536-20.2020
10.1002/dneu.20818
10.1038/nature04170
10.1073/pnas.1912055117
10.1126/science.aaf4382
10.3389/fncel.2018.00079
10.1016/S0898-6568(98)00042-4
10.1093/brain/awz099
10.1016/j.cell.2015.01.028
10.1016/j.cellsig.2004.12.011
10.1016/j.molbrainres.2005.04.015
10.1101/2024.03.21.586202
10.1016/j.celrep.2017.04.007
10.1074/jbc.M600933200
10.1002/ana.21425
10.1126/sciadv.abl8809
10.1523/JNEUROSCI.2911-10.2010
10.1242/jcs.038950
10.1111/jnc.15883
ContentType Journal Article
Copyright 2025. The Author(s).
COPYRIGHT 2025 BioMed Central Ltd.
Copyright_xml – notice: 2025. The Author(s).
– notice: COPYRIGHT 2025 BioMed Central Ltd.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOA
DOI 10.1186/s13024-025-00839-8
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
CrossRef


MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1750-1326
EndPage 35
ExternalDocumentID oai_doaj_org_article_d5aa6b281fe24ba3bc12b7540eeb8f94
A839045644
40340943
10_1186_s13024_025_00839_8
Genre Journal Article
Review
GroupedDBID ---
0R~
123
29M
2WC
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABIVO
ABUWG
ACGFO
ACGFS
ACIHN
ACMJI
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HH5
HMCUK
HYE
IAO
IHR
INH
INR
IPY
ITC
KQ8
LGEZI
LOTEE
M1P
M~E
NADUK
NXXTH
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
TR2
TUS
UKHRP
WOQ
WOW
~8M
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7X8
PPXIY
PJZUB
PUEGO
ID FETCH-LOGICAL-c433t-cbf67524f17ca55d9cd6d79b88324f3029611ad279e7a38fe13e30c736a1ac9b3
IEDL.DBID DOA
ISSN 1750-1326
IngestDate Wed Aug 27 00:48:25 EDT 2025
Fri Jul 11 18:13:58 EDT 2025
Fri May 16 01:10:28 EDT 2025
Tue Jun 10 20:53:06 EDT 2025
Mon May 12 02:38:39 EDT 2025
Tue Jul 01 04:40:15 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Phosphorylation
Post-translational modifications
Kinase
Neurodegeneration
TDP-43
Amyotrophic lateral sclerosis
Frontotemporal dementia
Phosphatase
Language English
License 2025. The Author(s).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c433t-cbf67524f17ca55d9cd6d79b88324f3029611ad279e7a38fe13e30c736a1ac9b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0000-0001-7954-5801
OpenAccessLink https://doaj.org/article/d5aa6b281fe24ba3bc12b7540eeb8f94
PMID 40340943
PQID 3202150827
PQPubID 23479
PageCount 35
ParticipantIDs doaj_primary_oai_doaj_org_article_d5aa6b281fe24ba3bc12b7540eeb8f94
proquest_miscellaneous_3202150827
gale_infotracmisc_A839045644
gale_infotracacademiconefile_A839045644
pubmed_primary_40340943
crossref_primary_10_1186_s13024_025_00839_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-05-08
PublicationDateYYYYMMDD 2025-05-08
PublicationDate_xml – month: 05
  year: 2025
  text: 2025-05-08
  day: 08
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Molecular neurodegeneration
PublicationTitleAlternate Mol Neurodegener
PublicationYear 2025
Publisher BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BMC
References F Kametani (839_CR167) 2009; 382
839_CR209
U Knippschild (839_CR159) 2005; 17
J Zhu (839_CR218) 2015; 10
Z Monahan (839_CR275) 2017; 36
D Posa (839_CR23) 2019; 56
H Sidibé (839_CR45) 2021; 144
TJ Nott (839_CR92) 2015; 57
G Lee (839_CR179) 2004; 279
Z Tang (839_CR184) 2015; 160
Y Iguchi (839_CR35) 2024; 223
E Rojas-Prats (839_CR26) 2021; 210
G Davidson (839_CR166) 2005; 438
AE Conicella (839_CR99) 2016; 24
M Neumann (839_CR77) 2021; 141
L Martinez-Gonzalez (839_CR279) 2023; 16
HY Li (839_CR31) 2011; 6
G Di Maira (839_CR236) 2005; 12
A Molliex (839_CR98) 2015; 163
Z Huang (839_CR197) 2018; 9
KA Ahmad (839_CR176) 2008; 48
JA Clark (839_CR229) 2016; 10
Y Komiya (839_CR199) 2008; 4
H Fujiwara (839_CR267) 2002; 4
M Hasegawa (839_CR11) 2008; 64
Q Lian (839_CR307) 2001; 167
JR Burrell (839_CR78) 2016; 388
DV Laurents (839_CR133) 2022; 9
K Sano (839_CR180) 2021; 9
E Sontag (839_CR302) 1996; 17
839_CR108
L Behrend (839_CR225) 2000; 79
Y Yang (839_CR245) 2003; 23
H-J Choi (839_CR141) 2020; 10
K Yasojima (839_CR142) 2000; 865
G Drewes (839_CR298) 1993; 336
S-C Ling (839_CR1) 2013; 79
Y Inukai (839_CR12) 2008; 582
839_CR223
A Siddiqui (839_CR145) 2021; 11
F Meggio (839_CR124) 2003; 17
H-J Chen (839_CR187) 2016; 139
M Neumann (839_CR55) 2006; 314
YM Jiang (839_CR149) 2005; 57
DK Choksi (839_CR16) 2014; 23
S Ray (839_CR274) 2020; 12
AK Walker (839_CR264) 2015; 130
L McGurk (839_CR86) 2018; 71
J Rowles (839_CR162) 1991; 88
K-W Lee (839_CR295) 2011; 31
L Martínez-González (839_CR131) 2021; 22
E Paplomata (839_CR240) 2014; 6
W-L Lin (839_CR6) 2008; 116
Y Kanai (839_CR233) 2004; 43
M Polymenidou (839_CR109) 2011; 14
LM Taylor (839_CR22) 2018; 13
X Deng (839_CR28) 2021; 221
CP Brangwynne (839_CR107) 2009; 324
M Weinreich (839_CR155) 1999; 18
MA Jeffries (839_CR208) 2016; 36
839_CR110
JL Brockman (839_CR242) 1992; 89
A Bah (839_CR121) 2016; 291
C González-Fernández (839_CR204) 2020; 15
839_CR114
C Lee (839_CR195) 2001; 107
AE Conicella (839_CR94) 2020; 117
839_CR116
SD Gross (839_CR164) 1998; 10
839_CR237
P Seshacharyulu (839_CR256) 2013; 335
CF Sephton (839_CR46) 2011; 286
CM Burke (839_CR53) 2020; 16
F Sivandzade (839_CR214) 2019; 21
JR Mann (839_CR262) 2019; 102
A-L Mahul-Mellier (839_CR282) 2014; 23
LM Igaz (839_CR112) 2011; 121
JS Tilstra (839_CR212) 2011; 2
MA Tremblay (839_CR285) 2010; 19
S Ussar (839_CR185) 2004; 279
P Aguilar-Calvo (839_CR54) 2017; 7
PT Nelson (839_CR9) 2011; 134
W Wang (839_CR65) 2017; 25
DP Hanger (839_CR271) 2009; 15
TJ Cohen (839_CR51) 2015; 6
H Sasaguri (839_CR73) 2016; 1647
M Vivoli-Vega (839_CR74) 2020; 21
F Laferrière (839_CR76) 2019; 22
J Walter (839_CR168) 2000; 275
NF Liachko (839_CR15) 2014; 10
X Jiang (839_CR203) 2021; 10
SJ Miller (839_CR239) 2002; 528
C Colombrita (839_CR129) 2009; 111
839_CR128
G Oshiro (839_CR153) 1999; 19
Y Bian (839_CR125) 2013; 3
A Amlie-Wolf (839_CR113) 2015; 10
AK Pandey (839_CR117) 2023; 18
839_CR130
DP Hanger (839_CR169) 2007; 282
SS Keating (839_CR96) 2023; 80
C-X Gong (839_CR297) 2000; 275
K Dutta (839_CR219) 2020; 40
OA Brady (839_CR266) 2011; 116
A-L Brown (839_CR43) 2022; 603
JH Hu (839_CR135) 2003; 85
839_CR134
S Wegmann (839_CR101) 2018; 37
NM Kanaan (839_CR273) 2020; 11
J Torres (839_CR238) 2001; 276
KA Josephs (839_CR10) 2014; 127
L Martínez-González (839_CR24) 2020; 10
F Kametani (839_CR75) 2016; 6
839_CR263
M Flajolet (839_CR288) 2007; 104
PW Baas (839_CR230) 2011; 71
K Leroy (839_CR139) 2007; 33
P Zhang (839_CR90) 2019; 8
DA Hicks (839_CR123) 2020; 45
TJ Singh (839_CR278) 1995; 64
C-X Gong (839_CR299) 1994; 61
TJ Cohen (839_CR48) 2012; 31
M Neumann (839_CR13) 2009; 117
839_CR143
F Liu (839_CR140) 2005; 22
KJ Fish (839_CR163) 1995; 270
ME Umoh (839_CR255) 2018; 10
Z Chen (839_CR280) 2015; 28
839_CR151
839_CR150
A Wang (839_CR33) 2018; 37
W Wang (839_CR64) 2013; 22
NF Liachko (839_CR122) 2016; 132
J Gu (839_CR254) 2018; 592
XR Ma (839_CR40) 2022; 603
C Schwab (839_CR7) 2008; 67
S Ambadipudi (839_CR272) 2017; 8
A Patel (839_CR100) 2015; 162
H-Z Long (839_CR234) 2021; 12
L Ojeda (839_CR235) 2011; 6
S Lee (839_CR29) 2022; 11
LM Iakoucheva (839_CR119) 2004; 32
J-Z Wang (839_CR301) 1995; 270
MA Cousin (839_CR258) 2001; 24
CJ Ladner (839_CR308) 1996; 55
839_CR277
SG Doll (839_CR62) 2022; 39
KE Paleologou (839_CR127) 2008; 283
S Nandakumar (839_CR243) 2021; 9
AL Nana (839_CR81) 2019; 137
T Sahana (839_CR205) 2021; 9
YM Ayala (839_CR37) 2011; 30
S Amit (839_CR201) 2002; 16
L Zhai (839_CR165) 1995; 270
V Swarup (839_CR216) 2011; 208
A Ferri (839_CR260) 2004; 90
NF Liachko (839_CR14) 2013; 74
D Pakravan (839_CR83) 2021; 11
NM Fong (839_CR251) 2000; 275
JP Anderson (839_CR268) 2006; 281
VI Ko (839_CR173) 2024; 196
Y-J Liu (839_CR137) 2015; 589
S Raffaele (839_CR210) 2021; 10
C Lagier-Tourenne (839_CR39) 2010; 19
MO Collins (839_CR120) 2008; 7
NF Liachko (839_CR310) 2010; 30
BS Johnson (839_CR106) 2009; 284
839_CR88
SD Dick (839_CR157) 2020; 28
839_CR84
839_CR85
839_CR296
839_CR174
W Wu (839_CR181) 2020; 15
J Sreedharan (839_CR69) 2008; 319
Y Yang (839_CR244) 2001; 21
G Vaca (839_CR27) 2021; 156
T Watanabe (839_CR226) 2015; 210
M Bollen (839_CR249) 2010; 35
E Buratti (839_CR66) 2009; 66
H Nakashima-Yasuda (839_CR4) 2007; 114
JK Cheong (839_CR160) 2011; 43
DW Litchfield (839_CR175) 2003; 369
GA de Oliveira (839_CR103) 2019; 118
N Ghoshal (839_CR144) 1999; 155
839_CR177
H Yu (839_CR89) 2021; 371
G Li (839_CR170) 2004; 279
P-H Kuo (839_CR38) 2014; 42
NH Alami (839_CR59) 2014; 81
I Owen (839_CR97) 2019; 20
JM Kim (839_CR152) 2003; 532
S Ranganathan (839_CR248) 2010; 4
839_CR182
839_CR72
839_CR186
M Gardiner (839_CR269) 2008; 415
K Ono (839_CR189) 2000; 12
A Rahman (839_CR306) 2006; 113
Y Lin (839_CR104) 2015; 60
T Arai (839_CR82) 2006; 351
T Zhang (839_CR198) 2018; 72
C González-Fernández (839_CR202) 2019; 56
C Feijoo (839_CR291) 2005; 118
J Gu (839_CR287) 2020; 30
X Sun (839_CR146) 2000; 275
KA Josephs (839_CR5) 2008; 70
S Higashi (839_CR3) 2007; 1184
CX Gong (839_CR294) 1995; 65
839_CR193
M Okochi (839_CR172) 2000; 275
839_CR196
BL Chen (839_CR232) 2006; 103
T Arai (839_CR8) 2009; 117
PJ Kennelly (839_CR115) 1996; 178
EM Blalock (839_CR138) 2004; 101
S Gonfloni (839_CR148) 2012; 2012
NT Seyfried (839_CR105) 2010; 9
C Liu (839_CR200) 2002; 108
V Vingtdeux (839_CR136) 2011; 121
A Kozeleková (839_CR126) 2022; 10
839_CR95
839_CR93
W Qian (839_CR309) 2011; 23
I Kounatidis (839_CR213) 2017; 19
J Rouse (839_CR221) 1994; 78
R Sahu (839_CR206) 2021; 100
A Montagnoli (839_CR156) 2002; 21
HJ Dyson (839_CR118) 2011; 44
SN Rhoads (839_CR270) 2018; 29
M Budini (839_CR50) 2017; 10
B Schittek (839_CR161) 2014; 13
Y Carlomagno (839_CR188) 2014; 9
L Sun (839_CR21) 2018; 12
CX Gong (839_CR293) 1993; 61
C Alquezar (839_CR19) 2016; 11
Z Liu (839_CR276) 2020; 27
SZ Imam (839_CR283) 2011; 31
CX Gong (839_CR305) 1994; 62
839_CR42
A Ishii (839_CR178) 2007; 581
Q Deng (839_CR265) 2014; 34
839_CR41
E Vielhaber (839_CR194) 2000; 20
E Källstig (839_CR211) 2021; 22
E Tarasova (839_CR259) 2018; 83
AS Correia (839_CR215) 2015; 10
W Zhao (839_CR217) 2015; 273
S Sato (839_CR191) 2006; 98
M Aikio (839_CR56) 2025; 44
C-X Gong (839_CR292) 1994; 341
NB Nedelsky (839_CR102) 2019; 15
C Bao (839_CR227) 2021; 41
S Ghosh (839_CR183) 2008; 8
P Derkinderen (839_CR284) 2005; 25
S Kumar (839_CR132) 2021; 16
CM Dewey (839_CR47) 2011; 31
839_CR36
S Boeynaems (839_CR91) 2018; 28
839_CR34
W Wang (839_CR63) 2016; 22
M Štalekar (839_CR111) 2015; 293
IG Salado (839_CR17) 2014; 57
839_CR30
K Tomizawa (839_CR192) 2001; 492
MF Ferreira (839_CR158) 2000; 20
A Jackson (839_CR154) 1993; 13
Y Khalfallah (839_CR49) 2018; 8
X Sun (839_CR147) 2000; 275
R Wagey (839_CR261) 1997; 4
A Sakakibara (839_CR231) 2013; 3
MM Koseoglu (839_CR246) 2019; 67
JM Kyriakis (839_CR190) 2001; 81
A Roth (839_CR228) 2022; 14
ES Pinarbasi (839_CR61) 2018; 8
T Nonaka (839_CR18) 2016; 291
E Kabashi (839_CR71) 2008; 40
T Obata (839_CR224) 2000; 28
S Brahmachari (839_CR281) 2016; 126
IN Foltz (839_CR222) 1997; 272
W Li (839_CR32) 2017; 292
E Sontag (839_CR304) 2004; 63
839_CR67
839_CR303
PT Nelson (839_CR2) 2019; 142
C Schwab (839_CR171) 2000; 21
AF Rosenberger (839_CR290) 2016; 13
839_CR60
E-J Kim (839_CR80) 2012; 22
CG Otte (839_CR87) 2020; 146
R Tournebize (839_CR250) 1997; 16
AT Bademosi (839_CR44) 2022; 38
GS Pesiridis (839_CR70) 2009; 18
DS Iimoto (839_CR289) 1990; 507
Y Tian (839_CR25) 2021; 161
LI Grad (839_CR79) 2017; 7
N Rezaei-Ghaleh (839_CR68) 2012; 13
F Krach (839_CR20) 2018; 136
839_CR57
YM Ayala (839_CR58) 2008; 121
S Ranganathan (839_CR247) 2003; 162
M Goedert (839_CR300) 1995; 65
839_CR52
J Xiao (839_CR207) 2012; 122
DM Virshup (839_CR253) 2009; 33
F Rusnak (839_CR257) 2000; 80
ML Gasparri (839_CR241) 2018; 144
T Zarubin (839_CR220) 2005; 15
IE Vega (839_CR286) 2005; 138
W Morishita (839_CR252) 2001; 32
References_xml – volume: 35
  start-page: 450
  issue: 8
  year: 2010
  ident: 839_CR249
  publication-title: Trends Biochem Sci
  doi: 10.1016/j.tibs.2010.03.002
– volume: 88
  start-page: 9548
  issue: 21
  year: 1991
  ident: 839_CR162
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.88.21.9548
– volume: 32
  start-page: 1133
  issue: 6
  year: 2001
  ident: 839_CR252
  publication-title: Neuron
  doi: 10.1016/S0896-6273(01)00554-2
– volume: 134
  start-page: 1506
  issue: 5
  year: 2011
  ident: 839_CR9
  publication-title: Brain
  doi: 10.1093/brain/awr053
– volume: 31
  start-page: 6963
  issue: 19
  year: 2011
  ident: 839_CR295
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.6513-10.2011
– ident: 839_CR116
  doi: 10.1093/nar/gkq1104
– volume: 292
  start-page: 5089
  issue: 12
  year: 2017
  ident: 839_CR32
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M116.753913
– volume: 8
  start-page: 7083
  issue: 1
  year: 2018
  ident: 839_CR61
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-25008-4
– volume: 27
  start-page: 363
  issue: 4
  year: 2020
  ident: 839_CR276
  publication-title: Nat Struct Mol Biol
  doi: 10.1038/s41594-020-0399-3
– volume: 11
  start-page: 3972
  issue: 24
  year: 2022
  ident: 839_CR29
  publication-title: Cells
  doi: 10.3390/cells11243972
– volume: 276
  start-page: 993
  issue: 2
  year: 2001
  ident: 839_CR238
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M009134200
– volume: 270
  start-page: 12717
  issue: 21
  year: 1995
  ident: 839_CR165
  publication-title: J Biol Chem
  doi: 10.1074/jbc.270.21.12717
– volume: 23
  start-page: 2557
  issue: 7
  year: 2003
  ident: 839_CR245
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.23-07-02557.2003
– volume: 162
  start-page: 1066
  issue: 5
  year: 2015
  ident: 839_CR100
  publication-title: Cell
  doi: 10.1016/j.cell.2015.07.047
– ident: 839_CR186
  doi: 10.1016/j.bbamcr.2006.10.005
– ident: 839_CR237
  doi: 10.1016/j.bbamcr.2014.04.020
– volume: 22
  start-page: 1942
  issue: 8
  year: 2005
  ident: 839_CR140
  publication-title: Eur J Neurosci
  doi: 10.1111/j.1460-9568.2005.04391.x
– volume: 56
  start-page: 6777
  year: 2019
  ident: 839_CR202
  publication-title: Mol Neurobiol
  doi: 10.1007/s12035-019-1547-9
– volume: 33
  start-page: 43
  issue: 1
  year: 2007
  ident: 839_CR139
  publication-title: Neuropathol Appl Neurobiol
  doi: 10.1111/j.1365-2990.2006.00795.x
– volume: 10
  start-page: 675
  issue: 10
  year: 2020
  ident: 839_CR141
  publication-title: Brain Sci
  doi: 10.3390/brainsci10100675
– volume: 10
  issue: 10
  year: 2015
  ident: 839_CR215
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0140248
– volume: 6
  start-page: 154
  issue: 4
  year: 2014
  ident: 839_CR240
  publication-title: Therapeutic advances in medical oncology
  doi: 10.1177/1758834014530023
– volume: 111
  start-page: 1051
  issue: 4
  year: 2009
  ident: 839_CR129
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2009.06383.x
– volume: 273
  start-page: 24
  year: 2015
  ident: 839_CR217
  publication-title: Exp Neurol
  doi: 10.1016/j.expneurol.2015.07.019
– volume: 2012
  issue: 1
  year: 2012
  ident: 839_CR148
  publication-title: International journal of cell biology
– volume: 14
  start-page: 459
  issue: 4
  year: 2011
  ident: 839_CR109
  publication-title: Nat Neurosci
  doi: 10.1038/nn.2779
– volume: 9
  start-page: 1
  year: 2021
  ident: 839_CR180
  publication-title: Acta Neuropathol Commun
  doi: 10.1186/s40478-021-01281-9
– volume: 291
  start-page: 5473
  issue: 11
  year: 2016
  ident: 839_CR18
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M115.695379
– volume: 121
  start-page: 337
  issue: 3
  year: 2011
  ident: 839_CR136
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-010-0759-x
– volume: 13
  start-page: 231
  issue: 1
  year: 2014
  ident: 839_CR161
  publication-title: Mol Cancer
  doi: 10.1186/1476-4598-13-231
– volume: 116
  start-page: 248
  issue: 2
  year: 2011
  ident: 839_CR266
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2010.07098.x
– volume: 12
  start-page: 668
  issue: 6
  year: 2005
  ident: 839_CR236
  publication-title: Cell Death Differ
  doi: 10.1038/sj.cdd.4401604
– volume: 161
  year: 2021
  ident: 839_CR25
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2021.105548
– volume: 8
  start-page: 1
  issue: 1
  year: 2017
  ident: 839_CR272
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-00480-0
– volume: 275
  start-page: 23523
  issue: 31
  year: 2000
  ident: 839_CR168
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M002850200
– volume: 10
  year: 2022
  ident: 839_CR126
  publication-title: Front Chem
  doi: 10.3389/fchem.2022.835733
– volume: 71
  start-page: 703
  issue: 5
  year: 2018
  ident: 839_CR86
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2018.07.002
– volume: 272
  start-page: 3296
  issue: 6
  year: 1997
  ident: 839_CR222
  publication-title: J Biol Chem
  doi: 10.1074/jbc.272.6.3296
– volume: 9
  year: 2021
  ident: 839_CR243
  publication-title: Frontiers in Cell and Developmental Biology
  doi: 10.3389/fcell.2021.698661
– volume: 10
  start-page: 204
  year: 2016
  ident: 839_CR229
  publication-title: Front Cell Neurosci
  doi: 10.3389/fncel.2016.00204
– volume: 80
  start-page: 95
  issue: 4
  year: 2023
  ident: 839_CR96
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-023-04739-2
– volume: 275
  start-page: 17237
  issue: 23
  year: 2000
  ident: 839_CR147
  publication-title: J Biol Chem
  doi: 10.1074/jbc.C000099200
– volume: 210
  start-page: 737
  issue: 5
  year: 2015
  ident: 839_CR226
  publication-title: J Cell Biol
  doi: 10.1083/jcb.201412075
– volume: 66
  start-page: 1
  year: 2009
  ident: 839_CR66
  publication-title: Adv Genet
  doi: 10.1016/S0065-2660(09)66001-6
– volume: 270
  start-page: 14875
  issue: 25
  year: 1995
  ident: 839_CR163
  publication-title: J Biol Chem
  doi: 10.1074/jbc.270.25.14875
– volume: 18
  start-page: 5334
  issue: 19
  year: 1999
  ident: 839_CR155
  publication-title: EMBO J
  doi: 10.1093/emboj/18.19.5334
– volume: 117
  start-page: 137
  issue: 2
  year: 2009
  ident: 839_CR13
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-008-0477-9
– volume: 4
  start-page: 160
  issue: 2
  year: 2002
  ident: 839_CR267
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb748
– volume: 532
  start-page: 29
  issue: 1–2
  year: 2003
  ident: 839_CR152
  publication-title: Mutat Res
  doi: 10.1016/j.mrfmmm.2003.08.008
– volume: 582
  start-page: 2899
  issue: 19
  year: 2008
  ident: 839_CR12
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2008.07.027
– volume: 17
  start-page: 349
  issue: 3
  year: 2003
  ident: 839_CR124
  publication-title: FASEB J
  doi: 10.1096/fj.02-0473rev
– volume: 1184
  start-page: 284
  year: 2007
  ident: 839_CR3
  publication-title: Brain Res
  doi: 10.1016/j.brainres.2007.09.048
– volume: 144
  start-page: 3461
  issue: 11
  year: 2021
  ident: 839_CR45
  publication-title: Brain
  doi: 10.1093/brain/awab217
– volume: 12
  start-page: 705
  issue: 8
  year: 2020
  ident: 839_CR274
  publication-title: Nat Chem
  doi: 10.1038/s41557-020-0465-9
– volume: 371
  start-page: eabb4309
  issue: 6529
  year: 2021
  ident: 839_CR89
  publication-title: Sci.
  doi: 10.1126/science.abb4309
– volume: 3
  start-page: 3460
  issue: 1
  year: 2013
  ident: 839_CR125
  publication-title: Sci Rep
  doi: 10.1038/srep03460
– volume: 282
  start-page: 23645
  issue: 32
  year: 2007
  ident: 839_CR169
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M703269200
– volume: 20
  start-page: 5501
  issue: 21
  year: 2019
  ident: 839_CR97
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms20215501
– volume: 107
  start-page: 855
  issue: 7
  year: 2001
  ident: 839_CR195
  publication-title: Cell
  doi: 10.1016/S0092-8674(01)00610-9
– volume: 43
  start-page: 513
  issue: 4
  year: 2004
  ident: 839_CR233
  publication-title: Neuron
  doi: 10.1016/j.neuron.2004.07.022
– volume: 36
  start-page: 9186
  issue: 35
  year: 2016
  ident: 839_CR208
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.1444-16.2016
– volume: 15
  start-page: 1580
  issue: 9
  year: 2020
  ident: 839_CR204
  publication-title: Neural Regen Res
  doi: 10.4103/1673-5374.276320
– volume: 28
  start-page: N67
  issue: 4
  year: 2000
  ident: 839_CR224
  publication-title: Crit Care Med
  doi: 10.1097/00003246-200004001-00008
– volume: 11
  start-page: 1
  issue: 1
  year: 2020
  ident: 839_CR273
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-16580-3
– volume: 60
  start-page: 208
  issue: 2
  year: 2015
  ident: 839_CR104
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2015.08.018
– volume: 70
  start-page: 1850
  issue: 19 Part 2
  year: 2008
  ident: 839_CR5
  publication-title: Neurol.
  doi: 10.1212/01.wnl.0000304041.09418.b1
– volume: 21
  start-page: 503
  issue: 4
  year: 2000
  ident: 839_CR171
  publication-title: Neurobiol Aging
  doi: 10.1016/S0197-4580(00)00110-X
– ident: 839_CR150
  doi: 10.1371/journal.pone.0046185
– ident: 839_CR151
  doi: 10.1126/scitranslmed.aaf3962
– volume: 8
  start-page: 7551
  issue: 1
  year: 2018
  ident: 839_CR49
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-25767-0
– volume: 7
  start-page: 1
  issue: 1
  year: 2017
  ident: 839_CR54
  publication-title: Sci Rep
  doi: 10.1038/srep43295
– volume: 32
  start-page: 1037
  issue: 3
  year: 2004
  ident: 839_CR119
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkh253
– volume: 7
  issue: 8
  year: 2017
  ident: 839_CR79
  publication-title: Cold Spring Harb Perspect Med
  doi: 10.1101/cshperspect.a024117
– volume: 146
  year: 2020
  ident: 839_CR87
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2020.105078
– volume: 83
  start-page: 674
  year: 2018
  ident: 839_CR259
  publication-title: Biochem Mosc
  doi: 10.1134/S0006297918060056
– volume: 155
  start-page: 1163
  issue: 4
  year: 1999
  ident: 839_CR144
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)65219-4
– ident: 839_CR88
  doi: 10.1016/j.nbd.2020.105051
– volume: 6
  start-page: 5845
  issue: 1
  year: 2015
  ident: 839_CR51
  publication-title: Nat Commun
  doi: 10.1038/ncomms6845
– volume: 18
  start-page: R156
  issue: 2
  year: 2009
  ident: 839_CR70
  publication-title: Human Mole Gene
  doi: 10.1093/hmg/ddp303
– volume: 78
  start-page: 1027
  issue: 6
  year: 1994
  ident: 839_CR221
  publication-title: Cell
  doi: 10.1016/0092-8674(94)90277-1
– volume: 19
  start-page: 4888
  issue: 7
  year: 1999
  ident: 839_CR153
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.19.7.4888
– volume: 20
  start-page: 4888
  issue: 13
  year: 2000
  ident: 839_CR194
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.20.13.4888-4899.2000
– ident: 839_CR209
  doi: 10.1002/glia.23606
– volume: 132
  start-page: 545
  issue: 4
  year: 2016
  ident: 839_CR122
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-016-1600-y
– volume: 44
  issue: 1
  year: 2025
  ident: 839_CR56
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2024.115205
– volume: 72
  start-page: 159
  year: 2018
  ident: 839_CR198
  publication-title: Neurobiol Aging
  doi: 10.1016/j.neurobiolaging.2018.08.025
– volume: 592
  start-page: 402
  issue: 3
  year: 2018
  ident: 839_CR254
  publication-title: FEBS Lett
  doi: 10.1002/1873-3468.12976
– volume: 10
  issue: 10
  year: 2015
  ident: 839_CR113
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0141836
– volume: 126
  start-page: 2970
  issue: 8
  year: 2016
  ident: 839_CR281
  publication-title: J Clin Investig
  doi: 10.1172/JCI85456
– volume: 118
  start-page: 397
  issue: 2
  year: 2005
  ident: 839_CR291
  publication-title: J Cell Sci
  doi: 10.1242/jcs.01655
– volume: 63
  start-page: 287
  issue: 4
  year: 2004
  ident: 839_CR304
  publication-title: J Neuropathol Exp Neurol
  doi: 10.1093/jnen/63.4.287
– volume: 10
  start-page: 1
  issue: 1
  year: 2020
  ident: 839_CR24
  publication-title: Sci Rep
  doi: 10.1038/s41598-020-61265-y
– volume: 137
  start-page: 27
  year: 2019
  ident: 839_CR81
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-018-1942-8
– volume: 21
  start-page: 3171
  issue: 12
  year: 2002
  ident: 839_CR156
  publication-title: EMBO J
  doi: 10.1093/emboj/cdf290
– volume: 275
  start-page: 390
  issue: 1
  year: 2000
  ident: 839_CR172
  publication-title: J Biol Chem
  doi: 10.1074/jbc.275.1.390
– volume: 10
  start-page: 565
  issue: 3
  year: 2021
  ident: 839_CR210
  publication-title: Cells
  doi: 10.3390/cells10030565
– volume: 61
  start-page: 921
  issue: 3
  year: 1993
  ident: 839_CR293
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.1993.tb03603.x
– volume: 101
  start-page: 2173
  issue: 7
  year: 2004
  ident: 839_CR138
  publication-title: Proc Natl Acad Sci
  doi: 10.1073/pnas.0308512100
– volume: 16
  start-page: 5537
  issue: 18
  year: 1997
  ident: 839_CR250
  publication-title: Embo j
  doi: 10.1093/emboj/16.18.5537
– volume: 25
  start-page: 6584
  issue: 28
  year: 2005
  ident: 839_CR284
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.1487-05.2005
– volume: 22
  start-page: 8975
  issue: 16
  year: 2021
  ident: 839_CR131
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms22168975
– volume: 341
  start-page: 94
  issue: 1
  year: 1994
  ident: 839_CR292
  publication-title: FEBS Lett
  doi: 10.1016/0014-5793(94)80247-5
– volume: 23
  start-page: 2858
  issue: 11
  year: 2014
  ident: 839_CR282
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddt674
– volume: 13
  start-page: 930
  issue: 7
  year: 2012
  ident: 839_CR68
  publication-title: ChemBioChem
  doi: 10.1002/cbic.201200093
– volume: 6
  issue: 8
  year: 2011
  ident: 839_CR235
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0023414
– ident: 839_CR114
  doi: 10.1126/scitranslmed.adf9735
– ident: 839_CR193
  doi: 10.1101/2021.10.06.21264635
– volume: 61
  start-page: 765
  issue: 4
  year: 1994
  ident: 839_CR299
  publication-title: Neuroscience
  doi: 10.1016/0306-4522(94)90400-6
– volume: 178
  start-page: 4759
  issue: 16
  year: 1996
  ident: 839_CR115
  publication-title: J Bacteriol
  doi: 10.1128/jb.178.16.4759-4764.1996
– volume: 162
  start-page: 823
  issue: 3
  year: 2003
  ident: 839_CR247
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)63879-5
– volume: 4
  start-page: 68
  issue: 2
  year: 2008
  ident: 839_CR199
  publication-title: Organogenesis
  doi: 10.4161/org.4.2.5851
– volume: 12
  year: 2021
  ident: 839_CR234
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2021.648636
– volume: 67
  start-page: 1
  issue: 1
  year: 2019
  ident: 839_CR246
  publication-title: J Alzheimers Dis
  doi: 10.3233/JAD-180874
– volume: 507
  start-page: 273
  issue: 2
  year: 1990
  ident: 839_CR289
  publication-title: Brain Res
  doi: 10.1016/0006-8993(90)90282-G
– volume: 23
  start-page: 1025
  issue: 4
  year: 2014
  ident: 839_CR16
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddt498
– volume: 141
  start-page: 137
  issue: 1
  year: 2021
  ident: 839_CR77
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-020-02242-7
– volume: 80
  start-page: 1483
  issue: 4
  year: 2000
  ident: 839_CR257
  publication-title: Physiol Rev
  doi: 10.1152/physrev.2000.80.4.1483
– volume: 10
  issue: 12
  year: 2014
  ident: 839_CR15
  publication-title: PLoS Genet
  doi: 10.1371/journal.pgen.1004803
– volume: 492
  start-page: 221
  issue: 3
  year: 2001
  ident: 839_CR192
  publication-title: FEBS Lett
  doi: 10.1016/S0014-5793(01)02256-6
– volume: 89
  start-page: 9454
  issue: 20
  year: 1992
  ident: 839_CR242
  publication-title: Proc Natl Acad Sci
  doi: 10.1073/pnas.89.20.9454
– volume: 9
  year: 2022
  ident: 839_CR133
  publication-title: Front Mol Biosci
  doi: 10.3389/fmolb.2022.906437
– volume: 319
  start-page: 1668
  issue: 5870
  year: 2008
  ident: 839_CR69
  publication-title: Science
  doi: 10.1126/science.1154584
– volume: 37
  issue: 5
  year: 2018
  ident: 839_CR33
  publication-title: EMBO J
  doi: 10.15252/embj.201797452
– volume: 9
  start-page: 969
  issue: 8
  year: 2021
  ident: 839_CR205
  publication-title: Biomedicines
  doi: 10.3390/biomedicines9080969
– volume: 81
  start-page: 536
  issue: 3
  year: 2014
  ident: 839_CR59
  publication-title: Neuron
  doi: 10.1016/j.neuron.2013.12.018
– volume: 156
  start-page: 379
  issue: 3
  year: 2021
  ident: 839_CR27
  publication-title: J Neurochem
  doi: 10.1111/jnc.15118
– volume: 12
  start-page: 1
  issue: 1
  year: 2000
  ident: 839_CR189
  publication-title: Cell Signal
  doi: 10.1016/S0898-6568(99)00071-6
– ident: 839_CR110
  doi: 10.1093/brain/awt029
– volume: 210
  year: 2021
  ident: 839_CR26
  publication-title: Eur J Med Chem
  doi: 10.1016/j.ejmech.2020.112968
– volume: 22
  start-page: 4706
  issue: 23
  year: 2013
  ident: 839_CR64
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddt319
– volume: 31
  start-page: 1098
  issue: 5
  year: 2011
  ident: 839_CR47
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.01279-10
– volume: 28
  start-page: 420
  issue: 6
  year: 2018
  ident: 839_CR91
  publication-title: Trends Cell Biol
  doi: 10.1016/j.tcb.2018.02.004
– volume: 581
  start-page: 4711
  issue: 24
  year: 2007
  ident: 839_CR178
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2007.08.067
– volume: 528
  start-page: 145
  issue: 1–3
  year: 2002
  ident: 839_CR239
  publication-title: FEBS Lett
  doi: 10.1016/S0014-5793(02)03274-X
– volume: 19
  start-page: R46
  issue: R1
  year: 2010
  ident: 839_CR39
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddq137
– ident: 839_CR85
  doi: 10.1016/j.neuron.2019.01.048
– volume: 19
  start-page: 721
  issue: 2
  year: 2010
  ident: 839_CR285
  publication-title: Arg Journal of Alzheimer's Disease
  doi: 10.3233/JAD-2010-1271
– volume: 351
  start-page: 602
  issue: 3
  year: 2006
  ident: 839_CR82
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2006.10.093
– volume: 286
  start-page: 1204
  issue: 2
  year: 2011
  ident: 839_CR46
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.190884
– volume: 65
  start-page: 2804
  issue: 6
  year: 1995
  ident: 839_CR300
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.1995.65062804.x
– volume: 37
  issue: 7
  year: 2018
  ident: 839_CR101
  publication-title: EMBO J
  doi: 10.15252/embj.201798049
– volume: 17
  start-page: 1201
  issue: 6
  year: 1996
  ident: 839_CR302
  publication-title: Neuron
  doi: 10.1016/S0896-6273(00)80250-0
– volume: 118
  start-page: 289
  year: 2019
  ident: 839_CR103
  publication-title: Adv Protein Chem Struct Biol
  doi: 10.1016/bs.apcsb.2019.08.002
– volume: 382
  start-page: 405
  issue: 2
  year: 2009
  ident: 839_CR167
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2009.03.038
– ident: 839_CR263
  doi: 10.7554/eLife.39578
– volume: 223
  issue: 2
  year: 2024
  ident: 839_CR35
  publication-title: J Cell Biol
  doi: 10.1083/jcb.202302048
– volume: 116
  start-page: 205
  issue: 2
  year: 2008
  ident: 839_CR6
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-008-0408-9
– volume: 15
  start-page: 272
  issue: 5
  year: 2019
  ident: 839_CR102
  publication-title: Nat Rev Neurol
  doi: 10.1038/s41582-019-0157-5
– ident: 839_CR177
  doi: 10.1074/jbc.M200486200
– ident: 839_CR60
  doi: 10.1016/j.celrep.2019.10.061
– volume: 388
  start-page: 919
  issue: 10047
  year: 2016
  ident: 839_CR78
  publication-title: The Lancet
  doi: 10.1016/S0140-6736(16)00737-6
– volume: 31
  start-page: 1241
  issue: 5
  year: 2012
  ident: 839_CR48
  publication-title: EMBO J
  doi: 10.1038/emboj.2011.471
– ident: 839_CR303
  doi: 10.1006/exnr.2001.7630
– ident: 839_CR143
  doi: 10.1101/2023.06.21.546009
– volume: 167
  start-page: 158
  issue: 1
  year: 2001
  ident: 839_CR307
  publication-title: Exp Neurol
  doi: 10.1006/exnr.2000.7534
– volume: 139
  start-page: 1417
  issue: 5
  year: 2016
  ident: 839_CR187
  publication-title: Brain
  doi: 10.1093/brain/aww028
– volume: 10
  start-page: 839
  issue: 4
  year: 2021
  ident: 839_CR203
  publication-title: Cells
  doi: 10.3390/cells10040839
– volume: 10
  issue: 11
  year: 2015
  ident: 839_CR218
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0142296
– volume: 44
  start-page: 467
  issue: 4
  year: 2011
  ident: 839_CR118
  publication-title: Q Rev Biophys
  doi: 10.1017/S0033583511000060
– volume: 23
  start-page: 617
  issue: 4
  year: 2011
  ident: 839_CR309
  publication-title: J Alzheimers Dis
  doi: 10.3233/JAD-2010-100987
– volume: 81
  start-page: 807
  issue: 2
  year: 2001
  ident: 839_CR190
  publication-title: Physiol Rev
  doi: 10.1152/physrev.2001.81.2.807
– volume: 45
  start-page: 1354
  issue: 6
  year: 2020
  ident: 839_CR123
  publication-title: Neurochem Res
  doi: 10.1007/s11064-019-02832-2
– volume: 6
  start-page: e23075
  issue: 8
  year: 2011
  ident: 839_CR31
  publication-title: PloS one.
  doi: 10.1371/journal.pone.0023075
– volume: 9
  issue: 3
  year: 2014
  ident: 839_CR188
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0090452
– volume: 8
  year: 2019
  ident: 839_CR90
  publication-title: Elife
  doi: 10.7554/eLife.39578
– volume: 21
  start-page: 2661
  issue: 8
  year: 2001
  ident: 839_CR244
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.21-08-02661.2001
– volume: 6
  start-page: 1
  issue: 1
  year: 2016
  ident: 839_CR75
  publication-title: Sci Rep
  doi: 10.1038/srep23281
– ident: 839_CR93
  doi: 10.1074/jbc.AC117.001037
– volume: 136
  start-page: 405
  issue: 3
  year: 2018
  ident: 839_CR20
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-018-1870-7
– ident: 839_CR36
  doi: 10.1016/j.pneurobio.2022.102229
– volume: 100
  issue: 7–8
  year: 2021
  ident: 839_CR206
  publication-title: Eur J Cell Biol
  doi: 10.1016/j.ejcb.2021.151179
– volume: 104
  start-page: 4159
  issue: 10
  year: 2007
  ident: 839_CR288
  publication-title: Proc Natl Acad Sci
  doi: 10.1073/pnas.0611236104
– volume: 15
  issue: 4
  year: 2020
  ident: 839_CR181
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0232019
– volume: 369
  start-page: 1
  issue: 1
  year: 2003
  ident: 839_CR175
  publication-title: Biochemical Journal
  doi: 10.1042/bj20021469
– volume: 291
  start-page: 6696
  issue: 13
  year: 2016
  ident: 839_CR121
  publication-title: J Biol Chem
  doi: 10.1074/jbc.R115.695056
– volume: 20
  start-page: 242
  issue: 1
  year: 2000
  ident: 839_CR158
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.20.1.242-248.2000
– volume: 22
  start-page: 3875
  issue: 8
  year: 2021
  ident: 839_CR211
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms22083875
– ident: 839_CR182
  doi: 10.1016/S0021-9258(17)41790-X
– volume: 196
  year: 2024
  ident: 839_CR173
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2024.106516
– volume: 127
  start-page: 441
  issue: 3
  year: 2014
  ident: 839_CR10
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-013-1211-9
– volume: 7
  start-page: 1331
  issue: 7
  year: 2008
  ident: 839_CR120
  publication-title: Mol Cell Proteomics
  doi: 10.1074/mcp.M700564-MCP200
– volume: 39
  issue: 13
  year: 2022
  ident: 839_CR62
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2022.111007
– volume: 67
  start-page: 1159
  issue: 12
  year: 2008
  ident: 839_CR7
  publication-title: J Neuropathol Exp Neurol
  doi: 10.1097/NEN.0b013e31818e8951
– volume: 284
  start-page: 20329
  issue: 30
  year: 2009
  ident: 839_CR106
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M109.010264
– volume: 335
  start-page: 9
  issue: 1
  year: 2013
  ident: 839_CR256
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2013.02.036
– ident: 839_CR108
  doi: 10.1101/2024.08.19.608477
– volume: 55
  start-page: 924
  issue: 8
  year: 1996
  ident: 839_CR308
  publication-title: J Neuropathol Exp Neurol
  doi: 10.1097/00005072-199608000-00008
– volume: 114
  start-page: 221
  issue: 3
  year: 2007
  ident: 839_CR4
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-007-0261-2
– volume: 221
  issue: 1
  year: 2021
  ident: 839_CR28
  publication-title: J Cell Biol
  doi: 10.1083/jcb.202103033
– volume: 18
  start-page: 1938
  issue: 9
  year: 2023
  ident: 839_CR117
  publication-title: ACS Chem Biol
  doi: 10.1021/acschembio.3c00068
– volume: 24
  start-page: 659
  issue: 11
  year: 2001
  ident: 839_CR258
  publication-title: Trends Neurosci
  doi: 10.1016/S0166-2236(00)01930-5
– volume: 38
  start-page: 889
  issue: 9
  year: 2022
  ident: 839_CR44
  publication-title: Trends Genet
  doi: 10.1016/j.tig.2022.06.004
– ident: 839_CR67
  doi: 10.1038/s41586-024-07487-w
– volume: 314
  start-page: 130
  issue: 5796
  year: 2006
  ident: 839_CR55
  publication-title: Science
  doi: 10.1126/science.1134108
– ident: 839_CR42
  doi: 10.1038/s41593-018-0300-4
– volume: 28
  start-page: 115
  year: 2015
  ident: 839_CR280
  publication-title: Curr Opin Chem Biol
  doi: 10.1016/j.cbpa.2015.07.001
– volume: 108
  start-page: 837
  issue: 6
  year: 2002
  ident: 839_CR200
  publication-title: Cell
  doi: 10.1016/S0092-8674(02)00685-2
– volume: 15
  start-page: 11
  issue: 1
  year: 2005
  ident: 839_CR220
  publication-title: Cell Res
  doi: 10.1038/sj.cr.7290257
– volume: 79
  start-page: 416
  issue: 3
  year: 2013
  ident: 839_CR1
  publication-title: Neuron
  doi: 10.1016/j.neuron.2013.07.033
– volume: 42
  start-page: 4712
  issue: 7
  year: 2014
  ident: 839_CR38
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkt1407
– volume: 163
  start-page: 123
  issue: 1
  year: 2015
  ident: 839_CR98
  publication-title: Cell
  doi: 10.1016/j.cell.2015.09.015
– volume: 275
  start-page: 35034
  issue: 45
  year: 2000
  ident: 839_CR251
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M005541200
– volume: 11
  year: 2021
  ident: 839_CR145
  publication-title: Front Oncol
  doi: 10.3389/fonc.2021.733700
– volume: 64
  start-page: 1420
  issue: 3
  year: 1995
  ident: 839_CR278
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.1995.64031420.x
– volume: 275
  start-page: 5535
  issue: 8
  year: 2000
  ident: 839_CR297
  publication-title: J Biol Chem
  doi: 10.1074/jbc.275.8.5535
– volume: 3
  issue: 7
  year: 2013
  ident: 839_CR231
  publication-title: Open Biol
  doi: 10.1098/rsob.130061
– ident: 839_CR130
  doi: 10.1016/j.nbd.2011.12.002
– volume: 589
  start-page: 432
  issue: 4
  year: 2015
  ident: 839_CR137
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2014.12.029
– volume: 865
  start-page: 116
  issue: 1
  year: 2000
  ident: 839_CR142
  publication-title: Brain Res
  doi: 10.1016/S0006-8993(00)02200-9
– volume: 2
  start-page: 449
  issue: 6
  year: 2011
  ident: 839_CR212
  publication-title: Aging Dis
– volume: 336
  start-page: 425
  issue: 3
  year: 1993
  ident: 839_CR298
  publication-title: FEBS Lett
  doi: 10.1016/0014-5793(93)80850-T
– volume: 102
  start-page: 321
  issue: 2
  year: 2019
  ident: 839_CR262
  publication-title: Neuron
  doi: 10.1016/j.neuron.2019.01.048
– volume: 13
  start-page: 2899
  issue: 5
  year: 1993
  ident: 839_CR154
  publication-title: Mol Cell Biol
– volume: 16
  start-page: 1243277
  year: 2023
  ident: 839_CR279
  publication-title: Front Mol Neurosci
  doi: 10.3389/fnmol.2023.1243277
– ident: 839_CR57
  doi: 10.1101/2025.02.28.639952
– volume: 57
  start-page: 2755
  issue: 6
  year: 2014
  ident: 839_CR17
  publication-title: J Med Chem.
  doi: 10.1021/jm500065f
– volume: 34
  start-page: 7802
  issue: 23
  year: 2014
  ident: 839_CR265
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.0172-14.2014
– volume: 90
  start-page: 1237
  issue: 5
  year: 2004
  ident: 839_CR260
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2004.02588.x
– volume: 74
  start-page: 39
  issue: 1
  year: 2013
  ident: 839_CR14
  publication-title: Ann Neurol
  doi: 10.1002/ana.23870
– volume: 57
  start-page: 936
  issue: 5
  year: 2015
  ident: 839_CR92
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2015.01.013
– volume: 603
  start-page: 131
  issue: 7899
  year: 2022
  ident: 839_CR43
  publication-title: Nature
  doi: 10.1038/s41586-022-04436-3
– volume: 36
  start-page: 2951
  issue: 20
  year: 2017
  ident: 839_CR275
  publication-title: Embo j
  doi: 10.15252/embj.201696394
– volume: 279
  start-page: 6834
  issue: 8
  year: 2004
  ident: 839_CR179
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M312760200
– volume: 11
  start-page: 548
  issue: 4
  year: 2021
  ident: 839_CR83
  publication-title: Biomolecules
  doi: 10.3390/biom11040548
– volume: 16
  start-page: 1
  year: 2021
  ident: 839_CR132
  publication-title: Mol Neurodegener
  doi: 10.1186/s13024-020-00420-5
– volume: 25
  start-page: 127
  issue: 1
  year: 2017
  ident: 839_CR65
  publication-title: Mol Ther
  doi: 10.1016/j.ymthe.2016.10.013
– volume: 603
  start-page: 124
  issue: 7899
  year: 2022
  ident: 839_CR40
  publication-title: Nature
  doi: 10.1038/s41586-022-04424-7
– ident: 839_CR34
  doi: 10.15252/embj.2021108443
– volume: 283
  start-page: 16895
  issue: 24
  year: 2008
  ident: 839_CR127
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M800747200
– volume: 31
  start-page: 157
  issue: 1
  year: 2011
  ident: 839_CR283
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.1833-10.2011
– volume: 415
  start-page: 297
  issue: 2
  year: 2008
  ident: 839_CR269
  publication-title: Biochemical Journal
  doi: 10.1042/BJ20081135
– volume: 103
  start-page: 4723
  issue: 12
  year: 2006
  ident: 839_CR232
  publication-title: Proc Natl Acad Sci
  doi: 10.1073/pnas.0506806103
– volume: 16
  issue: 4
  year: 2020
  ident: 839_CR53
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1008495
– volume: 130
  start-page: 643
  year: 2015
  ident: 839_CR264
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-015-1460-x
– ident: 839_CR41
  doi: 10.1038/s41593-018-0293-z
– ident: 839_CR52
  doi: 10.1111/nan.12836
– volume: 10
  start-page: 170
  year: 2017
  ident: 839_CR50
  publication-title: Front Mol Neurosci
  doi: 10.3389/fnmol.2017.00170
– volume: 33
  start-page: 537
  issue: 5
  year: 2009
  ident: 839_CR253
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2009.02.015
– volume: 22
  start-page: 65
  issue: 1
  year: 2019
  ident: 839_CR76
  publication-title: Nat Neurosci
  doi: 10.1038/s41593-018-0294-y
– volume: 9
  start-page: 705
  issue: 4
  year: 2010
  ident: 839_CR105
  publication-title: Mol Cell Proteomics
  doi: 10.1074/mcp.M800390-MCP200
– volume: 24
  start-page: 1537
  issue: 9
  year: 2016
  ident: 839_CR99
  publication-title: Structure
  doi: 10.1016/j.str.2016.07.007
– volume: 14
  start-page: 1345
  issue: 5
  year: 2022
  ident: 839_CR228
  publication-title: Cancers
  doi: 10.3390/cancers14051345
– volume: 30
  start-page: 277
  issue: 2
  year: 2011
  ident: 839_CR37
  publication-title: EMBO J
  doi: 10.1038/emboj.2010.310
– volume: 13
  start-page: 1
  issue: 1
  year: 2018
  ident: 839_CR22
  publication-title: Mol Neurodegener
  doi: 10.1186/s13024-018-0237-9
– volume: 1647
  start-page: 57
  year: 2016
  ident: 839_CR73
  publication-title: Brain Res
  doi: 10.1016/j.brainres.2016.04.069
– ident: 839_CR84
  doi: 10.1016/j.neuron.2019.02.038
– volume: 41
  start-page: 669
  year: 2021
  ident: 839_CR227
  publication-title: Cell Mol Neurobiol
  doi: 10.1007/s10571-020-00875-6
– volume: 98
  start-page: 1573
  issue: 5
  year: 2006
  ident: 839_CR191
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2006.04059.x
– volume: 57
  start-page: 236
  issue: 2
  year: 2005
  ident: 839_CR149
  publication-title: Ann Neurol
  doi: 10.1002/ana.20379
– volume: 4
  start-page: 350
  issue: 5
  year: 1997
  ident: 839_CR261
  publication-title: Neurobiol Dis
  doi: 10.1006/nbdi.1997.0145
– volume: 117
  start-page: 125
  issue: 2
  year: 2009
  ident: 839_CR8
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-008-0480-1
– volume: 62
  start-page: 803
  issue: 2
  year: 1994
  ident: 839_CR305
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.1994.62020803.x
– volume: 122
  start-page: 1167
  issue: 6
  year: 2012
  ident: 839_CR207
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2012.07871.x
– volume: 30
  start-page: 283
  issue: 2
  year: 2020
  ident: 839_CR287
  publication-title: Brain Pathol
  doi: 10.1111/bpa.12775
– ident: 839_CR174
  doi: 10.21203/rs.3.rs-5334588/v1
– ident: 839_CR72
  doi: 10.1016/j.bbrc.2012.07.071
– volume: 43
  start-page: 465
  issue: 4
  year: 2011
  ident: 839_CR160
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2010.12.004
– volume: 4
  start-page: 11
  year: 2010
  ident: 839_CR248
  publication-title: The open pathology journal
  doi: 10.2174/1874375701004010011
– volume: 22
  start-page: 251
  issue: 2
  year: 2012
  ident: 839_CR80
  publication-title: Cereb Cortex
  doi: 10.1093/cercor/bhr004
– volume: 48
  start-page: 179
  year: 2008
  ident: 839_CR176
  publication-title: Adv Enzyme Regul
  doi: 10.1016/j.advenzreg.2008.04.002
– volume: 275
  start-page: 7470
  issue: 11
  year: 2000
  ident: 839_CR146
  publication-title: J Biol Chem
  doi: 10.1074/jbc.275.11.7470
– volume: 15
  start-page: 112
  issue: 3
  year: 2009
  ident: 839_CR271
  publication-title: Trends Mol Med
  doi: 10.1016/j.molmed.2009.01.003
– volume: 22
  start-page: 869
  issue: 8
  year: 2016
  ident: 839_CR63
  publication-title: Nat Med
  doi: 10.1038/nm.4130
– volume: 16
  start-page: 1066
  issue: 9
  year: 2002
  ident: 839_CR201
  publication-title: Genes Dev
  doi: 10.1101/gad.230302
– ident: 839_CR30
  doi: 10.1021/acs.jmedchem.1c01942
– volume: 9
  start-page: 218
  year: 2018
  ident: 839_CR197
  publication-title: Front Neurol
  doi: 10.3389/fneur.2018.00218
– volume: 56
  start-page: 2424
  issue: 4
  year: 2019
  ident: 839_CR23
  publication-title: Mol Neurobiol
  doi: 10.1007/s12035-018-1249-8
– volume: 11
  start-page: 36
  issue: 1
  year: 2016
  ident: 839_CR19
  publication-title: Mol Neurodegener
  doi: 10.1186/s13024-016-0102-7
– volume: 113
  start-page: 219
  year: 2006
  ident: 839_CR306
  publication-title: J Neural Transm
  doi: 10.1007/s00702-005-0313-5
– volume: 279
  start-page: 43861
  issue: 42
  year: 2004
  ident: 839_CR185
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M406240200
– volume: 8
  start-page: 837
  issue: 11
  year: 2008
  ident: 839_CR183
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri2423
– ident: 839_CR296
  doi: 10.1038/cddis.2014.175
– volume: 21
  start-page: 6259
  issue: 17
  year: 2020
  ident: 839_CR74
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21176259
– volume: 324
  start-page: 1729
  issue: 5935
  year: 2009
  ident: 839_CR107
  publication-title: Science
  doi: 10.1126/science.1172046
– volume: 28
  start-page: 954
  issue: 8
  year: 2020
  ident: 839_CR157
  publication-title: Structure
  doi: 10.1016/j.str.2020.05.010
– volume: 10
  start-page: 48
  issue: 1
  year: 2018
  ident: 839_CR255
  publication-title: EMBO Mol Med
  doi: 10.15252/emmm.201708202
– volume: 29
  start-page: 1786
  issue: 15
  year: 2018
  ident: 839_CR270
  publication-title: Mol Biol Cell
  doi: 10.1091/mbc.E17-12-0735
– volume: 293
  start-page: 157
  year: 2015
  ident: 839_CR111
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2015.02.046
– volume: 121
  start-page: 726
  issue: 2
  year: 2011
  ident: 839_CR112
  publication-title: J Clin Investig
  doi: 10.1172/JCI44867
– volume: 144
  start-page: 2313
  year: 2018
  ident: 839_CR241
  publication-title: J Cancer Res Clin Oncol
  doi: 10.1007/s00432-018-2737-y
– ident: 839_CR277
  doi: 10.1016/j.jbc.2022.102191
– volume: 21
  year: 2019
  ident: 839_CR214
  publication-title: Redox Biol
  doi: 10.1016/j.redox.2018.11.017
– volume: 208
  start-page: 2429
  issue: 12
  year: 2011
  ident: 839_CR216
  publication-title: J Exp Med
  doi: 10.1084/jem.20111313
– volume: 79
  start-page: 240
  issue: 4
  year: 2000
  ident: 839_CR225
  publication-title: Eur J Cell Biol
  doi: 10.1078/S0171-9335(04)70027-8
– volume: 13
  start-page: 1
  year: 2016
  ident: 839_CR290
  publication-title: J Neuroinflammation
  doi: 10.1186/s12974-015-0470-x
– volume: 40
  start-page: 572
  issue: 5
  year: 2008
  ident: 839_CR71
  publication-title: Nat Genet
  doi: 10.1038/ng.132
– volume: 270
  start-page: 4854
  issue: 9
  year: 1995
  ident: 839_CR301
  publication-title: J Biol Chem
  doi: 10.1074/jbc.270.9.4854
– volume: 279
  start-page: 15938
  issue: 16
  year: 2004
  ident: 839_CR170
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M314116200
– volume: 65
  start-page: 732
  issue: 2
  year: 1995
  ident: 839_CR294
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.1995.65020732.x
– volume: 85
  start-page: 432
  issue: 2
  year: 2003
  ident: 839_CR135
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.2003.01670.x
– ident: 839_CR223
  doi: 10.1093/emboj/18.23.6845
– volume: 40
  start-page: 5137
  issue: 26
  year: 2020
  ident: 839_CR219
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.0536-20.2020
– volume: 71
  start-page: 403
  issue: 6
  year: 2011
  ident: 839_CR230
  publication-title: Dev Neurobiol
  doi: 10.1002/dneu.20818
– volume: 438
  start-page: 867
  issue: 7069
  year: 2005
  ident: 839_CR166
  publication-title: Nature
  doi: 10.1038/nature04170
– volume: 117
  start-page: 5883
  issue: 11
  year: 2020
  ident: 839_CR94
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1912055117
– ident: 839_CR95
  doi: 10.1126/science.aaf4382
– volume: 12
  start-page: 79
  year: 2018
  ident: 839_CR21
  publication-title: Front Cell Neurosci
  doi: 10.3389/fncel.2018.00079
– volume: 10
  start-page: 699
  issue: 10
  year: 1998
  ident: 839_CR164
  publication-title: Cell Signal
  doi: 10.1016/S0898-6568(98)00042-4
– volume: 142
  start-page: 1503
  issue: 6
  year: 2019
  ident: 839_CR2
  publication-title: Brain
  doi: 10.1093/brain/awz099
– volume: 160
  start-page: 729
  issue: 4
  year: 2015
  ident: 839_CR184
  publication-title: Cell
  doi: 10.1016/j.cell.2015.01.028
– volume: 17
  start-page: 675
  issue: 6
  year: 2005
  ident: 839_CR159
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2004.12.011
– volume: 138
  start-page: 135
  issue: 2
  year: 2005
  ident: 839_CR286
  publication-title: Brain Res Mol Brain Res
  doi: 10.1016/j.molbrainres.2005.04.015
– ident: 839_CR128
  doi: 10.1101/2024.03.21.586202
– volume: 19
  start-page: 836
  issue: 4
  year: 2017
  ident: 839_CR213
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2017.04.007
– volume: 281
  start-page: 29739
  issue: 40
  year: 2006
  ident: 839_CR268
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M600933200
– volume: 64
  start-page: 60
  issue: 1
  year: 2008
  ident: 839_CR11
  publication-title: Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society
  doi: 10.1002/ana.21425
– ident: 839_CR134
  doi: 10.1126/sciadv.abl8809
– volume: 30
  start-page: 16208
  issue: 48
  year: 2010
  ident: 839_CR310
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.2911-10.2010
– volume: 121
  start-page: 3778
  issue: Pt 22
  year: 2008
  ident: 839_CR58
  publication-title: J Cell Sci
  doi: 10.1242/jcs.038950
– ident: 839_CR196
  doi: 10.1111/jnc.15883
SSID ssj0047005
Score 2.40814
SecondaryResourceType review_article
Snippet Increased phosphorylation of TDP-43 is a pathological hallmark of several neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and...
Abstract Increased phosphorylation of TDP-43 is a pathological hallmark of several neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS)...
SourceID doaj
proquest
gale
pubmed
crossref
SourceType Open Website
Aggregation Database
Index Database
StartPage 53
SubjectTerms Amino acids
Amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis - metabolism
Animals
Dementia
Development and progression
DNA-Binding Proteins - metabolism
Frontotemporal dementia
Humans
Nervous system diseases
Neurodegeneration
Neurodegenerative Diseases - metabolism
Neurophysiology
Phosphorylation
Phosphorylation - physiology
Post-translational modification
Post-translational modifications
TDP-43
Title Molecular mechanisms and consequences of TDP-43 phosphorylation in neurodegeneration
URI https://www.ncbi.nlm.nih.gov/pubmed/40340943
https://www.proquest.com/docview/3202150827
https://doaj.org/article/d5aa6b281fe24ba3bc12b7540eeb8f94
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagXLggoDwWyspICA4o6sb2-nFMoVW1UqsKttLeLD9pD5utNttD_z0zzqbqwoELUqJItqU433jiGXv8DSGfctYy19xX0plQiZrhJqHzoO4-ixyNYYXU5-xcnl6K2WK6eJDqC2PCenrgHrjDOHVOeqbrnJjwjvtQM6_AzkjJ62wKEyjMeYMz1f-DhYLBNRyR0fKww-05UWHqVrQ5TKV3pqHC1v_3P_kPS7PMOCfPybOtqUibvosvyKPUviT7TQtu8vKOfqYleLOsiu-T-dmQ5pYuEx7mve6WHXVtpOFBuDRdZTr_flEJTm-uVh3c67s-Fo5et7RQW8b0qxBRY-ErcnlyPP92Wm0TJlRBcL6pgs9g_zORaxXcdBpNiDIq4zWorcgAgZF17SJTJinHdU64BDoJiktXu2A8f0322lWb3hI6ERnEq6NHNpgopY4p1YpHVsuYVWQj8nXAz970vBi2-BNa2h5tC2jbgrbVI3KEEN-3RE7rUgCStltJ239JekS-oIAsat5m7YLbHiCADiOHlW3gVYUdB1oe7LQEjQk71R8HEVuswjCzNq1uO4vJ5JEgn6kRedPL_r7PYsLRF-bv_se3vCdPWRmNcOkDsrdZ36YPYN1s_Jg8Vgs1Jk-aZvZzBs-j4_OLH-MyvH8D3Fj65w
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Molecular+mechanisms+and+consequences+of+TDP-43+phosphorylation+in+neurodegeneration&rft.jtitle=Molecular+neurodegeneration&rft.au=Kellett%2C+Elise+A&rft.au=Bademosi%2C+Adekunle+T&rft.au=Walker%2C+Adam+K&rft.date=2025-05-08&rft.eissn=1750-1326&rft.volume=20&rft.issue=1&rft.spage=53&rft_id=info:doi/10.1186%2Fs13024-025-00839-8&rft_id=info%3Apmid%2F40340943&rft.externalDocID=40340943
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1750-1326&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1750-1326&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1750-1326&client=summon